YOLFTbeta
Celltrion Inc

Celltrion Inc

068270 · KO · Healthcare / Biotechnology

$179,400-900.00 (-0.50%)

Close Sep 18, 2026 · end-of-day

Market Stats

Previous Close$180,300
Open$182,000
Day Range$179,400 – $182,800
52-Week Range$158,500 – $239,047.63
Volume635.15K
Market Cap$41.36T
P/E (TTM)0.00
Forward P/E23.42
Dividend Yield0.39%
Beta0.30
50-Day Avg$186,138
200-Day Avg$190,013.67

Price History

Open in new tab
Loading price history…

About

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gastric cancer; Remsima SC and Yuflyma for rheumatoid arthritis and inflammatory bowel disease; Vegzelma for metastatic colorectal cancer and non-small cell lung cancer; Omlyclo for Asthma and urticaria; Eydenzelt for diabetic macular edema and wet age-related macular degeneration; Steqeyma for psoriasis and inflammatory bowel disease; Stoboclo/Osenvelt for osteoporosis; Avtozma for rheumatoid arthritis and active systemic juvenile idiopathic arthritis; Zymfentra for inflammatory bowel disease; and Regkirona for COVID-19, as well as CT-G07 for HIV/AIDS and Donerion Patch for Alzheimer's dementia symptoms. The company is also developing biosimilars, which are in Phase 3 clinical trials include CT-P44 for multiple myeloma, CT-P51 for melanoma and lung cancer, CT-P53 for multiple sclerosis, and CT-P55 for psoriasis, as well as CT-G20 for hypertrophic cardiomyopathy. It distributes its products in approximately 100 countries, including the United States and Europe. The company was founded in 2002 and is headquartered in Incheon, South Korea.

Company Details

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Woo-Sung Kee
Employees
2.96K
Headquarters
23, Academy-ro, Incheon, South Korea, Korea
Website
https://www.celltrion.com

Leadership

  • Mr. Woo-Sung KeeCo-CEO & Internal Director · b. 1961
  • Mr. Jin-Seok SeoCo-CEO & Inside Co-Chairman of the Board · b. 1984
  • Mr. Stephen YeumFounder
  • Mr. Min-Cheol ShinCFO, Director of Finance & Inside Director · b. 1971
  • Mr. Ji-Hoon ChoiDirector of Legal Affairs · b. 1971

Financials

Income Statement

Line item2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue$60.08B$83.69B$145.55B$180.95B$279.04B$350.20B$226.21B$471.05B$603.41B$670.58B$949.08B$982.07B$1.13T$1.85T$1.91T$2.28T$2.18T$3.56T$4.16T
Cost of Revenue$50.86B$36.14B$51.59B$39.43B$52.26B$93.91B$68.69B$129.91B$234.57B$273.98B$251.25B$431.17B$494.97B$821.45B$805.81B$1.25T$1.12T$1.88T$1.70T
Gross Profit$9.23B$47.55B$93.96B$141.52B$226.78B$256.28B$157.52B$341.14B$368.84B$396.60B$697.83B$550.91B$633.49B$1.03T$1.11T$1.03T$1.05T$1.68T$2.47T
Operating Income$1.65B$30.77B$71.75B$106.62B$179.31B$195.45B$99.85B$201.47B$258.95B$249.69B$499.59B$323.13B$381.53B$718.58B$756.86B$647.20B$651.48B$492.02B$1.16T
EBITDA$6.34B$17.35B$81.78B$125.91B$202.96B$241.44B$197.64B$263.84B$329.99B$348.23B$596.96B$443.89B$545.78B$840.51B$998.78B$873.17B$926.59B$1.07T$1.52T
Net Income$2.29B$14.57B$58.54B$108.37B$167.81B$174.43B$102.45B$112.68B$154.09B$177.99B$368.22B$245.76B$301.03B$517.76B$579.46B$537.84B$535.65B$422.69B$1.03T
R&D$771.86M$3.31B$5.76B$16.14B$19.15B$31.09B$25.39B$69.64B$37.32B$65.36B$79.66B$108.06B$113.57B$171.44B$125.77B$139.71B$161.11B$199.72B$210.70B
Interest Expense$1.23B$6.62B$2.46B$1.07B$2.60B$16.82B$32.12B$38.35B$29.71B$14.09B$14.67B$14.75B$10.83B$7.50B$8.24B$7.51B$9.67B$75.57B$75.47B

Balance Sheet

Line item2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets$61.46B$499.26B$559.20B$1.16T$1.41T$1.73T$1.98T$2.32T$2.75T$3.02T$3.29T$3.50T$3.86T$5.02T$5.67T$5.89T$19.92T$21.06T$22.33T
Total Liabilities$34.87B$279.55B$273.53B$375.57B$507.77B$682.77B$891.38B$974.60B$938.39B$822.97B$883.60B$907.85B$986.73B$1.59T$1.62T$1.62T$2.79T$3.48T$4.98T
Total Equity$25.31B$219.72B$285.67B$779.89B$899.55B$1.05T$1.09T$1.25T$1.69T$2.05T$2.29T$2.49T$2.76T$3.31T$3.92T$4.14T$16.98T$17.44T$17.21T
Cash$1.61B$302.47M$16.10B$29.18B$49.28B$53.16B$80.75B$108.75B$149.93B$268.41B$419.21B$410.55B$546.14B$684.29B$1.19T$551.19B$564.61B$996.43B$1.12T
Total Debt$27.26B$231.93B$248.65B$275.00B$416.87B$599.03B$749.46B$845.45B$795.86B$678.94B$640.92B$516.56B$495.37B$774.40B$744.36B$792.33B---
Net Debt$25.66B$231.63B$232.55B$245.82B$367.59B$545.87B$668.71B$736.70B$645.94B$410.54B$221.71B$106.01B$-50.77B$90.11B$-443.97B$241.15B$1.31T$1.17T$2.57T

Cash Flow

Line item2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow$2.61B$46.79B$44.95B$33.60B$62.76B$20.97B$137.08B$145.16B$77.57B$250.89B$485.98B$364.79B$473.99B$350.75B$911.16B$863.53M$537.16B$901.87B$646.05B
Investing Cash Flow------$-229.38B$-106.34B$-166.94B$-162.49B$-245.10B$-175.84B$-251.44B$-471.98B$-355.83B----
Financing Cash Flow$4.57B$19.53B$31.22B$242.90B$57.42B$129.42B$119.87B$-11.32B$130.43B$28.67B$-96.28B$-198.14B$-85.92B$265.99B$-69.28B$-350.22B---
Capital Expenditure$10.04B$61.20B$47.37B$141.39B$214.27B$114.96B$87.17B$135.39B$184.58B$178.29B$96.99B$187.82B$286.14B$541.39B$321.57B$311.99B$353.73B$333.52B$331.73B
Free Cash Flow$-7.43B$-14.42B$-2.41B$-107.79B$-151.51B$-93.99B$49.91B$9.77B$-107.02B$72.60B$388.99B$176.97B$187.86B$-190.65B$589.59B$-311.12B$183.43B$568.35B$314.32B
Dividends Paid$294.98M$52.93B--$8.69B$11.52B$2.59B$68.40K$714.23K--$3.78M$3.78M$3.78M$3.78M$102.45B$51.66B$103.60B$153.76B

Earnings

Report DateOct 29, 2026Aug 6, 2026May 7, 2026Mar 3, 2026Nov 14, 2025Aug 14, 2025May 15, 2025Feb 25, 2025Nov 14, 2024Aug 14, 2024May 16, 2024Feb 29, 2024Nov 14, 2023Aug 14, 2023May 12, 2023Mar 3, 2023Nov 14, 2022Aug 16, 2022May 16, 2022Feb 15, 2022Nov 15, 2021Aug 17, 2021May 17, 2021Feb 22, 2021Nov 16, 2020Aug 14, 2020May 8, 2020Mar 19, 2020Nov 14, 2019Aug 14, 2019May 8, 2019Mar 18, 2019Nov 14, 2018Aug 8, 2018May 9, 2018Jan 19, 2018Nov 14, 2017Aug 11, 2017May 11, 2017Mar 9, 2017Nov 14, 2016Aug 12, 2016May 13, 2016Feb 16, 2016Nov 10, 2015Aug 4, 2015May 14, 2015Feb 17, 2015Nov 28, 2014Sep 3, 2014May 28, 2014Feb 26, 2014Nov 27, 2013Aug 28, 2013May 29, 2013Aug 14, 2012Mar 30, 2012Mar 30, 2011Nov 15, 2010
EPS Estimate$1622.68$1450.51$1036.51$1496.58$1070.53$783.28$617.04$900.60$753.80$208.99$29.87$566.38$956.79$961.13$870.18$869.80$737.91$778.20$1344.96$879.71$851.26$934.04$912.62$1087.89$707.03$730.14$724.06$615.78$514.11$660.50$507.72$638.30$673.98$788.05$734.83$755.26$282.34$417.99$444.25$361.19$330.98$374.54$198.56------------$321.81$271.35$169.76$217.52
EPS Actual-$1609.00$1576.00$2398.00$1436.19$262.86$484.43$1049.45$361.07$328.80$94.19$7.40$1361.42$901.80$1007.33$503.00$1013.03$1111.98$715.33$845.19$812.29$752.27$1159.24$740.36$1022.05$828.60$752.59$599.69$369.24$464.43$466.85$268.68$335.66$622.78$619.05$798.32$674.39$686.93$529.60$380.83$356.27$545.30$66.05$318.37$434.85$447.04$-115.04$83.70$111.89$517.17$111.54$-22.63$177.95$229.23$211.62$256.72$292.56$190.89$193.09
Surprise-10.93%52.05%60.23%34.16%-66.44%-21.49%16.53%-52.10%57.33%215.33%-98.69%42.29%-6.17%15.76%-42.17%37.28%42.89%-46.81%-3.92%-4.58%-19.46%27.02%-31.95%44.56%13.49%3.94%-2.61%-28.18%-29.69%-8.05%-57.91%-50.20%-20.97%-15.76%5.70%138.86%64.34%19.21%5.44%7.64%45.59%-66.74%-------------20.23%7.82%12.45%-11.23%
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-After-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketPre-marketPre-market------After-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap
$41.36T
Enterprise Value
$43.16T
Trailing P/E
0.00
Forward P/E
23.42
PEG Ratio
0.84
Price / Sales
8.45
Price / Book
2.26
Revenue (TTM)
$4.90T
Gross Profit (TTM)
$3.03T
EBITDA
$1.84T
Profit Margin
32.18%
Operating Margin
32.42%
Return on Equity
9.11%
Return on Assets
4.37%
Shares Outstanding
228.03M
Shares Float
158.75M
Beta
0.30
Dividend Yield
0.39%
Dividend Rate
$714.29
Payout Ratio
10.18%

Dividends

20251×
$714.29Dec 29, 2025
20241×
$654.11Dec 27, 2024
20231×
$436.07Dec 27, 2023
20221×
$327.05Dec 28, 2022
20211×
$628.95Dec 29, 2021
20121×
$16.28Dec 27, 2012
20111×
$73.14Dec 28, 2011
20101×
$54.85Dec 29, 2010
20071×
$36.57Dec 27, 2007
20061×
$36.57Dec 27, 2006

Stock Splits

  • Jun 4, 20261.05:1
  • Jun 9, 20251.04:1
  • Dec 27, 20241.05:1
  • Dec 28, 20221.04:1
  • Dec 29, 20211.02:1
  • Dec 29, 20201.02:1
  • Dec 27, 20191.05:1
  • Dec 27, 20181.02:1
  • Dec 27, 20171.02:1
  • Dec 28, 20161.05:1
  • Dec 29, 20151.03:1
  • Dec 29, 20141.05:1
  • Dec 27, 20131.03:1
  • Mar 4, 20131:2
  • Dec 27, 20121.15:1
  • May 24, 20121.5:1